Supplementation with Tex261 provides a possible preventive treatment for hypoxic pulmonary artery hypertension

• Egile Nagusiak: Shaokun Chen (Egilea), Xiaozhen Wei (Egilea), Xu Zhang (Egilea), Mengge Yao (Egilea), Zhihuang Qiu (Egilea), Liangwan Chen (Egilea), Li Zhang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objectives: Pulmonary artery hypertension (PAH) is a serious disease for which there is no effective treatment. Its pathogenesis is complex and has not yet been clarified. Tex261 is a protein-coding gene whose functional enrichment nodes include the transporter activity of COP II. However, the role...